Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3013516010 | Tasimelteon 20mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3013527012 | Tasimelteon 20mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3471671011 | Tasimelteon 20 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3471672016 | Product containing tasimelteon 20 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3488417013 | Product containing tasimelteon 20 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3571017014 | Product containing only tasimelteon 20 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3571018016 | Product containing only tasimelteon 20 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3683277013 | Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3683278015 | Tasimelteon 20 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3683279011 | Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 108461201000001111 | Tasimelteon 20 mg/1 each oral capsule | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Is a | Product containing tasimelteon | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Has active ingredient | Tasimelteon | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Has active ingredient | Tasimelteon | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Has basis of strength substance | Tasimelteon | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Has precise active ingredient | Tasimelteon | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Is a | Product containing tasimelteon in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tasimelteon 20 milligram/1 each conventional release oral capsule | Is a | Product containing only tasimelteon in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR